REAL Canadian Breast Cancer Alliance Collection
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Breast Cancer".
Deadline for manuscript submissions: 31 December 2026 | Viewed by 6891
Special Issue Editors
2. Division of Medical Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON M5S 1A1, Canada
Interests: brain metastases; breast cancer clinical trials; translational science
2. Faculty of Medicine and Health Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC V5Z 4E6, Canada
Interests: development of personalized oncology and the improvement of patient outcomes and survivorship programs
Special Issues, Collections and Topics in MDPI journals
2. Department of Medicine, McGill University, Montreal, QC H3G 2M1, Canada
Interests: breast cancer clinical trial and translational research
Special Issue Information
Dear Colleagues,
The Research Excellence, Active Leadership (REAL) Canadian Breast Cancer Alliance is a standing nucleus committee composed of clinical–academic physicians specializing in breast cancer from across Canada and Breast Cancer Canada, a patient organization. The REAL Alliance was formed and launched in December 2023 due to recognition that national collaboration is needed to address an unmet need: evidence-based guidance and recommendations, with timely updates, for use with public and government stakeholders for equitable and timely access to treatment and care for breast cancer patients. This special issue will provide guidance to physicians, other health care professionals, and policy makers for improving outcomes for patients with breast cancer across Canada.
Dr. Katarzyna J. Jerzak
Dr. Nathalie LeVasseur
Dr. Nathaniel Bouganim
Dr. Mita Manna
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Publisher’s Notice
As stated above, the central purpose of this Special Issue is to present research from the REAL Canadian Breast Cancer Alliance Collection. Given this purpose, the Guest Editors’ contribution to this Special Issue may be greater than typical of standard Special Issues published by MDPI. Further details on MDPI's Special Issue guidelines can be found here: https://www.mdpi.com/special_issues_guidelines. The Editorial Office and Editor-in-Chief of Current Oncology has approved this, and MDPI’s standard manuscript editorial processing procedure (https://www.mdpi.com/editorial_process) will be applied to all submissions. As per our standard procedure, Guest Editors are excluded from participating in the editorial process for their submission and/or for submissions from persons with whom a potential conflict of interest may exist. More details on MDPI’s Conflicts of Interest policy for reviewers and editors can be found here: https://www.mdpi.com/ethics#_bookmark22.
Keywords
- HER2-positive
- hormone receptor-positive
- triple-negative
- metastatic breast cancer
- early-stage breast cancer
- Canadian consensus recommendations
- evidence-based
- REAL Alliance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
